Related Experiment Videos
New flavonoids from Avicennia marina
M Sharaf1, M A El-Ansari, N A Saleh
1Phytochemistry and Plant Systematics Department, National Research Centre, Dokki-12311, Cairo, Egypt.
Fitoterapia
|June 14, 2000
Summary
Researchers identified two novel flavonoids from the methanol extract of Avicennia marina aerial parts. These compounds, luteolin 7-O-methylether 3'-O-beta-D-glucoside and its galactoside analogue, expand the known phytochemical profile of this plant species.
Area of Science:
- Phytochemistry
- Natural Product Chemistry
- Marine Botany
Background:
- Avicennia marina is a mangrove species with a rich history of traditional medicinal uses.
- Previous phytochemical investigations have identified various flavonoids and other secondary metabolites in Avicennia species.
- Understanding the chemical constituents of Avicennia marina is crucial for exploring its potential pharmacological applications.
Purpose of the Study:
- To isolate and characterize novel flavonoid compounds from the aerial parts of Avicennia marina.
- To contribute to the comprehensive phytochemical analysis of the Avicennia genus.
- To identify new natural products with potential biological activities.
Main Methods:
- Methanol extraction of Avicennia marina aerial parts.
- Chromatographic separation techniques (e.g., column chromatography) for isolation of compounds.
- Spectroscopic methods (e.g., NMR, Mass Spectrometry) for structural elucidation of the isolated flavonoids.
Main Results:
- Isolation and identification of two new flavonoids: luteolin 7-O-methylether 3 omino-beta-D-glucoside and its galactoside analogue.
- Confirmation of known flavonoids: luteolin 7-O-methylether, chrysoeriol 7-O-glucoside, and isorhamnetin 3-O-rutinoside.
- The new compounds represent novel glycosylated derivatives of known flavonoid structures.
Conclusions:
- The study successfully identified two previously undescribed flavonoid glycosides from Avicennia marina.
- These findings expand the known chemical diversity of flavonoids within the Avicennia genus.
- The identified compounds warrant further investigation for their potential biological and pharmacological properties.